The first ever clinical study evaluating combined transcranial direct current stimulation (tDCS) and behaviour therapy could point to a new treatment for depression.
https://www.pharmalive.com/wp-content/uploads/2019/12/190116_0887_flow.jpg6671000Administratorhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngAdministrator2019-12-05 13:00:142020-01-02 19:50:03First Clinical Study Evaluating Combined tDCS And Behavior Therapy Could Point To A New Treatment For Depression